MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1530/eje-21-0230

Медицинская библиотека · European journal of endocrinology · 2021

Long-term morbidity and mortality in patients diagnosed with an insulinoma.

Peltola Elina, Hannula Päivi, Huhtala Heini, Metso Saara, Sand Juhani, Laukkarinen Johanna, Tiikkainen Mirja, Sirén Jukka, Soinio Minna, Nuutila Pirjo, Moilanen Leena, Laaksonen David E, Ebeling Tapani, Arola Johanna, Schalin-Jäntti Camilla, Jaatinen Pia

Историческая статьяСтатьяПеревод в очереди

Аннотация

OBJECTIVE

Insulinomas are rare functional pancreatic neuroendocrine tumours. As previous data on the long-term prognosis of insulinoma patients are scarce, we studied the morbidity and mortality in the Finnish insulinoma cohort.

DESIGN

Retrospective cohort study.

METHODS

Incidence of endocrine, cardiovascular, gastrointestinal and psychiatric disorders, and cancers was compared in all the patients diagnosed with an insulinoma in Finland during 1980-2010 (n = 79, including two patients with multiple endocrine neoplasia type 1 syndrome), vs 316 matched controls, using the Mantel-Haenszel method. Overall survival was analysed with Kaplan-Meier and Cox regression analyses.

RESULTS

The median length of follow-up was 10.7 years for the patients and 12.2 years for the controls. The long-term incidence of atrial fibrillation (rate ratio (RR): 2.07 (95% CI: 1.02-4.22)), intestinal obstruction (18.65 (2.09-166.86)), and possibly breast (4.46 (1.29-15.39) and kidney cancers (RR not applicable) was increased among insulinoma patients vs controls, P < 0.05 for all comparisons. Endocrine disorders and pancreatic diseases were more frequent in the patients during the first year after insulinoma diagnosis, but not later on. The survival of patients with a non-metastatic insulinoma (n = 70) was similar to that of controls, but for patients with distant metastases (n = 9), the survival was significantly impaired (median 3.4 years).

CONCLUSIONS

The long-term prognosis of patients with a non-metastatic insulinoma is similar to the general population, except for an increased incidence of atrial fibrillation, intestinal obstruction, and possibly breast and kidney cancers. These results need to be confirmed in future studies. Metastatic insulinomas entail a markedly decreased survival.

Для цитирования: Peltola Elina, Hannula Päivi, Huhtala Heini, Metso Saara, Sand Juhani, Laukkarinen Johanna, Tiikkainen Mirja, Sirén Jukka, Soinio Minna, Nuutila Pirjo, Moilanen Leena, Laaksonen David E, Ebeling Tapani, Arola Johanna, Schalin-Jäntti Camilla, Jaatinen Pia. Long-term morbidity and mortality in patients diagnosed with an insulinoma.. European journal of endocrinology. 2021. DOI: 10.1530/eje-21-0230.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.